Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹239 Cr
P/E Ratio
8.82
P/B Ratio
1.14
Industry P/E
37.25
Debt to Equity
0
ROE
9.5 %
ROCE
12.48 %
Div. Yield
0.3 %
Book Value
586.94
EPS
76.09
CFO
₹39.13 Cr
EBITDA
₹129.39 Cr
Net Profit
₹112.89 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Coral Laboratories
| -12.23 | -9.11 | -11.29 | 76.17 | 34.04 | 35.03 | 7.71 |
|
BSE Healthcare
| -7.27 | -1.01 | -0.76 | 19.87 | 19.29 | 22.12 | 9.77 |
|
BSE Small Cap
| -12.38 | 0.32 | -4.19 | 2.45 | 17.96 | 35.18 | 15.87 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Coral Laboratories
| 81.91 | 35.01 | 3.55 | -0.10 | 116.01 | -62.14 | -60.41 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 425.60 | 6,920.24 | 25.22 | 12.5 | |
| 5,063.50 | 8,422.94 | 35.6 | 43.77 | |
| 680.85 | 6,674.72 | 75.6 | 4.01 | |
| 653.45 | 6,028.82 | 22.37 | 12.68 |
No Review & Analysis are available.
Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory,... antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India. Read more
Incorporated
1997
Chairman
--
Managing Director
--
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Coral Laboratories Ltd stood at ₹ 232 Cr as on 31-Dec-24
The share price of Coral Laboratories Ltd is ₹669.55 (BSE) as of 25-Apr-2025 IST. Coral Laboratories Ltd has given a return of 34.04% in the last 3 years.
Coral Laboratories Ltd has a market capitalisation of ₹ 239 Cr as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Coral Laboratories Ltd is 1.14 times as on 25-Apr-2025, a 78% discount to its peers’ median range of 5.15 times.
The P/E ratio of Coral Laboratories Ltd is 8.82 times as on 25-Apr-2025, a 76% discount to its peers’ median range of 37.25 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Coral Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Coral Laboratories Ltd.
Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.
The promoters of Coral Laboratories Ltd are Chetan Navinchandra Doshi and Coral India Finance And Housing Ltd.. They collectively own 71.51 per cent of the total equity. The chairman of the company is
There is no promoter pledging in Coral Laboratories Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,423
|
|
|
6,920
|
|
|
6,675
|
|
|
6,029
|
| Coral Laboratories Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
14.27
|
|
Operating margin(%)
|
24.01
|
|
Net Margin(%)
|
21.78
|
|
Dividend yield(%)
|
0.3
|
Yes, TTM profit after tax of Coral Laboratories Ltd was ₹27 Cr.
₹-30.45
(
